Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
NeuroOne Medical Technologies Corporation (NMTC) had Return on Investments of -46.92% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$1.86M |
|
$-2.38M |
|
$0.87M |
|
$0.99M |
|
$4.26M |
|
$-2.40M |
|
$0.02M |
|
$-2.38M |
|
$-2.38M |
|
$-2.38M |
|
$-2.38M |
|
$-2.38M |
|
$-2.38M |
|
$-2.40M |
|
$-2.34M |
|
8.48M |
|
8.48M |
|
$-0.28 |
|
$-0.28 |
|
| Balance Sheet Financials | |
$7.11M |
|
$0.23M |
|
$0.46M |
|
$7.57M |
|
$1.69M |
|
-- |
|
$0.80M |
|
$2.49M |
|
$5.08M |
|
$5.04M |
|
$5.08M |
|
8.62M |
|
| Cash Flow Statement Financials | |
$-4.44M |
|
$-0.08M |
|
$0.76M |
|
$6.57M |
|
$2.80M |
|
$-3.77M |
|
$0.70M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.21 |
|
-- |
|
-- |
|
-- |
|
-- |
|
53.18% |
|
-128.74% |
|
-128.74% |
|
-- |
|
-127.92% |
|
-127.92% |
|
$-4.52M |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
0.42 |
|
0.98 |
|
91.71 |
|
-46.92% |
|
-47.23% |
|
-31.47% |
|
|
Return on Investments |
-46.92% |
$0.59 |
|
$-0.53 |
|
$-0.52 |
|